Badana, Luvin C.

HRN: 23-56-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFUROXIME 1.5GM (VIAL)
09/21/2023
09/28/2023
IV
1.5 G
Q8h
Fistula In Ano
Waiting Final Action 
07/11/2024
CEFUROXIME 1.5GM (VIAL)
07/11/2024
07/18/2024
IV
1.5grams
Q8H
Fistula-in-Ano
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: